UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
OPERATING ACTIVITIES:
Net loss	$ (5,720)	$ 2,226	$ (21,007)	$ (23,853)
Adjustments to reconcile net loss to net cash used in operating activities:
(Recovery) Provision for bad debt			(821)	803	$ 1,135
Depreciation and amortization	11,504	11,471	35,928	33,145
Amortization of right-of-use asset			6,934	5,947
Stock-based compensation expense	11,018	2,365	32,375	6,587
Fair value changes in financial instruments			(4,664)	1,651
Fair value changes in business acquisitions contingencies	59	0	(3,472)	24,035
Deferred income taxes			1,892	232
Debt extinguishment costs				4,052
Other			460	68
Changes in operating assets and liabilities—net of acquisitions:
Accounts receivable and contract assets			7,301	(12,503)
Prepaid expenses and other current assets			(1,364)	(1,781)
Accounts payable and other accrued liabilities			(12,943)	(3,422)
Accrued payroll and benefits			(6,363)	61
Payment of contingent consideration			(19,457)	(15,549)
Change in operating leases			(6,634)	(5,765)
Net cash (used in) provided by operating activities			8,165	13,708
INVESTING ACTIVITIES:
Purchases of property and equipment			(5,414)	(5,405)
Proceeds received from corporate owned insurance			277
Proprietary software development and other software costs			(397)	(241)
Purchase price true ups			(439)	(8,562)
Cash paid for acquisitions—net of cash acquired			(21,342)	(36,480)
Net cash used in investing activities			(27,315)	(50,688)
FINANCING ACTIVITIES:
Proceeds from line of credit				109,000
Payments on line of credit				(72,000)
Proceeds from term loans				175,000
Repayment of term loan			(8,751)	(173,905)
Payment of contingent consideration			(10,722)	(9,605)
Repayment of finance leases			(2,906)	(1,884)
Debt issuance costs				(2,590)
Proceeds from issuance of common stock for exercised stock options			812	6,032
Dividend payment to the Series A-2 shareholders			(12,300)	(12,300)
Payments of deferred offering costs			(183)
Net cash (used in) provided by financing activities			(34,050)	17,748
CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH			(53,200)	(19,232)
Foreign exchange impact on cash balance			25	357
Beginning of year			146,741	34,881	34,881
End of period	$ 93,566	$ 16,006	93,566	16,006	$ 146,741
SUPPLEMENTAL DISCLOSURES OF CASH FLOWS INFORMATION:
Cash paid for interest			4,852	4,649
Cash paid for income tax			587	958
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Accrued purchases of property and equipment			881	1,171
Property and equipment purchased under finance leases			3,939	1,766
Common stock issued to acquire new businesses				6,020
Acquisitions unpaid contingent consideration			$ 6,777	35,352
Offering costs included in accounts payable and other accrued liabilities				389
Acquisitions contingent consideration paid in shares				$ 26,084